$20.75Average Price Target
The highest estimate is 40.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
This list is based on the watchlists of people on Stock Events who follow ARTV. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
FAQs
What is Artiva Biotherapeutics stock price today?▼
The current price of ARTV is $4.17 USD — it has decreased by -0.47% in the past 24 hours. Watch Artiva Biotherapeutics stock price performance more closely on the chart.
What is Artiva Biotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Artiva Biotherapeutics stocks are traded under the ticker ARTV.
Is Artiva Biotherapeutics stock price growing?▼
ARTV stock has fallen by -31.98% compared to the previous week, the month change is a -38.65% fall, over the last year Artiva Biotherapeutics has showed a +0.48% increase.
What is Artiva Biotherapeutics market cap?▼
Today Artiva Biotherapeutics has the market capitalization of 204.85M
When is the next Artiva Biotherapeutics earnings date?▼
Artiva Biotherapeutics is going to release the next earnings report on November 18, 2026.
What were Artiva Biotherapeutics earnings last quarter?▼
ARTV earnings for the last quarter are -0.63 USD per share, whereas the estimation was -0.63 USD resulting in a -0.79% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Artiva Biotherapeutics revenue for the last year?▼
Artiva Biotherapeutics revenue for the last year amounts to 0 USD.
What is Artiva Biotherapeutics net income for the last year?▼
ARTV net income for the last year is -83.87M USD.
How many employees does Artiva Biotherapeutics have?▼
As of November 2, 2026, the company has 115 employees.
In which sector is Artiva Biotherapeutics located?▼
Artiva Biotherapeutics operates in the Health & Wellness sector.
When did Artiva Biotherapeutics complete a stock split?▼
Artiva Biotherapeutics has not had any recent stock splits.
Where is Artiva Biotherapeutics headquartered?▼
Artiva Biotherapeutics is headquartered in SAN DIEGO, United States.